Antiplasmodial Activity among 7-Substituted 4-AQs
J ournal of Medicinal Chemistry, 1998, Vol. 41, No. 25 4925
(10) Posner, G. H.; McGarvey, D. J .; Oh, C. H.; Kumar, N.; Meshnick,
S. R.; Asawamahasadka, W. Structure-activity Relationships
of Lactone Ring-opened Analogues of the Antimalarial 1,2,4-
Trioxane Artemisinin. J . Med. Chem. 1995, 38, 607-612.
(11) (a) Collins, W. E.; J effery, G. M. Primaquine Resistance in
Plasmodium vivax. Am. J . Trop. Med. Hyg. 1996, 55, 243-249
and references therein. (b) Fryauff, D. J .; Baird, J . K.; Basri,
H.; Wiady, I.; Purnomo; Bangs, M. J .; Subianto, B.; Harjosu-
warno, S.; Tjitra, E.; Richie, T. L.; Hoffman, S. L. Halofantrine
and Primaquine for radical Cure of malaria in Irian J aya,
Indonesia. Ann. Trop. Med. Parasitol. 1997, 91, 7-16. (c) Idowu,
O. R.; Peggins, J . O.; Brewer, T. G.; Kelly, C. Metabolism of a
candidate 8-aminoquinoline antimalarial agent, WR 238605 by
rat liver microsomes. Drug Metab. Dispos. 1995, 23, 1-17. (d)
Hansch, C.; Leo, A. Substituent Constants for Correlation
Analysis in Chemistry and Biology; J ohn Wiley & Sons: New
York, 1979; pp 13-17.
(12) (a) De, D.; Byers, L. D.; Krogstad, D. J . Antimalarials: Synthesis
of 4-Aminoquinolines that Circumvent Drug Resistance in
Malaria Parasites. J . Heterocyclic Chem. 1997, 34, 315-320. (b)
De, D.; Mague, J . T.; Byers, L. D.; Krogstad, D. J . Synthesis of
(E)-2-(4,7-Dichloroquinolin-2-yl)-3-(dimethylamino)-2-propene-
1-al and its use as a Synthetic Intermediate. Tetrahedron Lett.
1995, 36, 205-208.
Refer en ces
(1) (a) World Health Report 1995 - Bridging the Gaps; World
Health Organization, Geneva Report, May 2, 1995. (b) Miller,
L. H.; Good, M. F.; Milon, G. Malaria Pathogenesis. Science 1994,
264, 1878-1884. (c) Malaria: Obstacles and Opportunities;
Oaks, S. C., J r., Mitchell, V. S., Pearson, G. W., Carpenter, C.
C., Eds.; Institute of Medicine: Washington, DC; 1991.
(2) For general articles and further information on chemistry and
biology of antimalarial drugs, see: (a) Murray, M. C.; Perkins,
M. E. Chemotherapy of Malaria. In Annual Reports in Medicinal
Chemistry; Bristol, J . A., Ed; Academic Press: San Diego, CA,
1996; pp 141-150. (b) Buss, A. D.; Waigh, R. D. Natural
Products as Leads for New Pharmaceuticals. In Burger’s Me-
dicinal Chemistry and Drug Discovery; Wolff, M. E., Ed; J ohn
Wiley & Sons: New York, 1995; pp 1021-1027. (c) Coatney, G.
R.; Cooper, W. C.; Eddy, N. B.; Greenberg, J . Survey of
Antimalarials Agents. Chemotherapy of Plasmodium gallina-
ceum infections, toxicity, correlation of structure and action.
Public Health Monograph no. 9: Washington, DC.; 1953. (d)
Krogstad, D. J .; De, D. Chloroquine: Modes of Action and
Resistance, and The Activity of Chloroquine Analogues. In
Malaria: Parasite Biology, Pathogenesis, and Protection; Sher-
man, I. W., Ed.; ASM Press: Washington, DC, 1998; pp 331-
339.
(3) Bloland, P. B.; Lackritz, E. M.; Kazembe, P. N.; Were, J . B.;
Steketee, R.; Campbell, C. C. Beyond Chloroquine: Implications
of Drug Resistance for Evaluating Malaria Therapeutic Efficacy
and Treatment Policy in Africa. J . Infect. Dis. 1993, 167, 932-
937.
(4) (a) Kinnamon, K. E.; Rothe, W. E. Biological screening in the
U.S. Army Antimalarial Drug Development Program. Am. J .
Trop. Med. Hyg. 1975, 24, 174-178. (b) Berliner, R. W.; Earle,
D. P., J r.; Taggart, J . V.; Zubrod, C. G.; Welch, W. L.; Conan, N.
J .; Bauman, E.; Scudder, S. T.; Shannon, J . A. Studies on the
Chemotherapy of the Human Malarias. VI. The Physiological
Disposition, Antimalarial Activity, and Toxicity of several
Derivatives of 4-aminoquinoline. J . Clin. Invest. 1948, 27, 98-
107. (c) Andersag, H.; Breitner, S.; J ung, H. Quinoline com-
pounds. US 2,233,970; Chem. Abstr. 1941, 35, 3771. (d) Ander-
sag, H.; Breitner, S.; J ung, H. Ger 683,692; Chem. Abstr. 1942,
36, 4973.
(5) (a) De, D.; Krogstad, F. M.; Cogswell, F. B.; Krogstad, D. J .
Aminoquinolines that Circumvent Resistance in Plasmodium
falciparum In Vitro. Am. J . Trop. Med. Hyg. 1996, 55, 579-
583. (b) Cogswell, F. B.; Preslan, J .; Spurlock, J . P.; Mack, P.
A.; Krogstad, F. M.; De, D. E.; George, W. J .; Krogstad, D. J .
44th American Society of Tropical Medicine and Hygiene Annual
Meeting, San Antonio, Nov 21, 1995. Abstr. No. 594. (c)
Krogstad, D. J .; De, D. Chloroquine analogues, their Preparation,
and Methods of Preventing and Treating Plasmodial Diseases.
PCT Int. Appl. WO 96 40138, 1995; Chem Abstr. 1997, 126,
113160r.
(6) Smart, B. E. Physical and Physicochemical Properties. In
Chemistry of Organic Fluorine Compounds II; Hudlicky, M.,
Pavlath, A. E., Eds.; ACS Monograph 187; American Chemical
Society: Washington, DC, 1995; pp 979-1003.
(7) O’Neill, P. M.; Harrison, A. C.; Storr, R. C.; Hawley, S. R.; Ward,
S. A.; Park, B. K. The Effect of Fluorine Substitution on the
Metabolism and Antimalarial Activity of Amodiaquine. J . Med.
Chem. 1994, 37, 1362-1370.
(8) O’Neill, P. M.; Tingle, M. D.; Mahmud, R.; Storr, R. C.; Ward,
S. A.; Park, B. K. The Effect of Fluorine Substitution on the
Haemotoxicity of Primaquine. Bio. Med. Chem. Lett. 1995, 20,
2309-2314.
(9) (a) Grigorov, M.; Weber, J .; Tronchet, J . M.; J efford, C. W.;
Milhous, W. K.; Maric, D. A QSAR study of the antimalarial
activity of some synthetic 1,2,4-trioxanes. J . Chem. Inf. Comput.
Sci. 1997, 37, 124-130. (b) Fleck, S. L.; Robinson, B. L.; Peters,
W. The chemotherapy of rodent malaria. LIV. Combinations of
‘Fenozan B07’ (Fenozan-50F), a difluorinated 3,3′-spirocyclopen-
tane 1,2,4-trioxane, with other drugs against drug-sensitive and
drug-resistant parasites. Ann. Trop. Med. Parasitol. 1997, 91,
33-39. (c) Fleck S. L.; Robinson, B. L.; Peters, W.; Thevin, F.;
Boulard, Y.; Glenat, C.; Caillard, V.; Landau, I. The chemo-
therapy of rodent malaria. LIII. ‘Fenozan B07’ (Fenozan-50F),
a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane: comparison
with some compounds of the artemisinin series. Ann. Trop. Med.
Parasitol. 1997, 91, 25-32. (d) Peters, W.; Robinson, B. L.;
Tovey, G.; Rossier, J . C.; J efford, C. W. The chemotherapy of
rodent malaria. L. The activities of some synthetic 1,2,4-
trioxanes against chloroquine-sensitive and chloroquine-resis-
tant parasites. Part 3: Observations on ‘Fenozan-50F’, a di-
fluorinated 3, 3′-spirocyclopentane 1,2,4-trioxane. Ann. Trop.
Med. Parasitol. 1993, 87, 111-123. (e) Pu, Y. M.; Torok, D. S.;
Ziffer, H. Synthesis and Antimalarial Activities of Several
Fluorinated Artemisinin Derivatives. J . Med. Chem. 1995, 38,
4120-4124.
(13) (a) Price, C. C.; Roberts, R. M. The Synthesis of 4-Hydroxyquino-
lines. I. Through ethoxymethylenemalonic ester. J . Am. Chem.
Soc. 1946, 68, 1204-1208. (b) Counsell, R. E.; Pocha, P.; Ranade,
V. V.; Sterngold, J .; Beierwaltes, W. H. Tumor Localizing Agents.
VII. Radioiodinated Quinoline Derivatives. J . Med. Chem. 1969,
12, 232-236. (c) Counsell, R. E.; Pocha, P.; Morales, J . O.;
Beierwaltes, W. H. Tumor Localizing Agents III. Radioiodinated
Quinoline Derivatives. J . Pharm. Sci. 1967, 56, 1042-1044. (d)
Conroy, A. E.; Mosher, H. S.; Whitmore, F. C. Heterocyclic Basic
Compounds. XII. 7-Bromo- and 7-Iodo-quinolines. J . Am. Chem.
Soc. 1949, 71, 3236-3237.
(14) Surrey, A. R.; Cutler, R. A. The Role of Phenol in the Reaction
of 4,7-Dichloroquinoline with Novol Diamine. J . Am. Chem. Soc.
1951, 73, 2623-2626.
(15) (a) De; D.; Seth, M.; Puri, S. K.; Chandra, S.; Bhaduri, A. P.
3-(Arylmethyl)-1-(3-diethylaminopropyl)pyrrolidines for revers-
ing the chloroquine resistance of chloroquine-resistant Plasmo-
dium species and process for its preparation. Eur. Pat. Appl.
EP562185, 1993; Chem. Abstr. 1994, 120, 106757p. (b) De, D.
Ph.D. Thesis, University of Gorakhpur, Gorakhpur, India, 1990.
(16) Bolton, P. H.; Mirau P. A.; Shafer, R. H.; J ames, T. L. Interaction
of the Antimalarial Drug Fluoroquine with DNA, tRNA, and
Poly(A): 19F NMR Chemical-Shift and Relaxation, Optical
Absorption, and Fluorescence Studies. Biopolymers 1981, 20,
435-449
(17) Everett, T. S. Nuclear Magnetic Resonance Spectroscopy of
Organofluorine Compounds. In Chemistry of Organic Fluorine
Compounds II; Hudlicky, M., Pavlath, A. E., Eds.; ACS Mono-
graph 187; American Chemical Society: Washington, DC, 1995;
pp 1037-1086.
(18) Bavetsias, V.; J ackman, A. L.; Kimbell, R.; Gibson, W.; Boyle,
F. T.; Bisset, G. M. F. Quinazoline Antifolate Thymidylate
Synthase Inhibitors: γ-Linked L-D, D-D, and D-L Dipeptide
Analogues of 2-Desamino-2-methyl-N10-propargyl-5,8-didi-
ethylaminezafolic acid (ICI 198583). J . Med. Chem. 1996, 39,
73-85.
(19) (a) Gribble, G. W.; Lord, P. D.; Skotnicki, J .; Dietz, S. E.; Eaton,
J . T.; J ohnson, J . L. Reactions of Sodium Borohydride in Acidic
Media. I. Reduction of Indoles and Alkylation of Aromatic
Amines with Carboxylic Acids. J . Am. Chem. Soc. 1974, 96,
7812-7814.
(20) (a) Umino, N.; Iwakuma, T.; Itoh, N. Sodium Acyloxyborohy-
drides as New Reducing Agents. I. Reduction of Carboxamides
to the Corresponding Amines. Tetrahedron Lett. 1976, 10, 763-
766. (b) Gribble, G. W.; J asinski, J . M.; Pellicone, J . T.; Panetta,
J . A. Synthesis 1978, 766-768.
(21) Marchini, P.; Liso, G.; Reho, A. Sodium Borohydride-carboxylic
Acid Systems. Useful Reagents for the Alkylation of Amines. J .
Org. Chem. 1975, 40, 3453-3456.
(22) Vennerstrom, J . L.; Ellis, W. Y.; Ager, A. L. J r.; Andersen, S.
L.; Gerena, L.; Milhous, W. K. Bisquinolines. 1. N,N-Bis(7-
chloroquinolin-4-yl)alkanediamines with Potential against Chlo-
roquine-Resistant Malaria. J . Med. Chem. 1992, 35, 2129-2134.
(23) Desjardins, R. E.; Canfield, C. J .; Haynes, J . D.; Chulay, J . D.
Quantitative Assessment of Antimalarial Activity in vitro by a
semiautomated microdilution technique. Antimicrob. Agents
Chemother. 1979, 16, 710-718.
(24) Teklehaimanot, A.; Nguyen-Dinh, P.; Collins, W. E.; Barber, A.
M.; Campbell, C. C. Evaluation of sporontocidal compounds
using gametocytes produced in vitro. Am. J . Trop. Med. Hyg.
1985, 34, 429-434.